• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅接受电休克治疗的抑郁症患者的系列地塞米松抑制试验。

Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy.

作者信息

Grunhaus L, Zelnik T, Albala A A, Rabin D, Haskett R F, Zis A P, Greden J F

机构信息

Department of Psychiatry, University of Michigan Medical Center, Ann Arbor 48109.

出版信息

J Affect Disord. 1987 Nov-Dec;13(3):233-40. doi: 10.1016/0165-0327(87)90042-5.

DOI:10.1016/0165-0327(87)90042-5
PMID:2960715
Abstract

Several systematic studies have evaluated serial dexamethasone suppression tests (DST) in patients with major depression who were treated with antidepressant medications. DST changes were noted to parallel clinical improvement in most recovering patients. If serial DSTs are a valid state-related correlate of depressive pathophysiology, all types of effective antidepressant treatment should result in DST 'normalization'. However, no treatment modalities other than antidepressant medications have been studied serially with systematic assessments. To test whether serial DSTs reflect clinical progress in depressives treated solely with electroconvulsive therapy (ECT), we studied weekly DSTs and Hamilton Rating Scales for Depression (HRSD) in 22 drug-free depressed patients. We observed progressive DST 'normalization' in most patients and moderately high correlations between weekly DST and HRSD values throughout treatment. Most patients receiving ECT became DST suppressors. In most patients the DST appeared to reflect the severity of depressive pathophysiology, perhaps providing serial feedback to clinicians monitoring the progress of treatment with ECT.

摘要

多项系统性研究评估了接受抗抑郁药物治疗的重度抑郁症患者的系列地塞米松抑制试验(DST)。在大多数病情好转的患者中,DST变化与临床改善情况平行。如果系列DST是与抑郁病理生理学相关的有效状态指标,那么所有类型的有效抗抑郁治疗都应导致DST“正常化”。然而,除抗抑郁药物外,尚未对其他治疗方式进行系统性系列评估研究。为了测试系列DST是否反映仅接受电休克治疗(ECT)的抑郁症患者的临床进展,我们对22名未服用药物的抑郁症患者进行了每周一次的DST和汉密尔顿抑郁量表(HRSD)研究。我们观察到大多数患者的DST逐渐“正常化”,且在整个治疗过程中,每周的DST与HRSD值之间存在中度高度相关性。大多数接受ECT治疗的患者成为DST抑制者。在大多数患者中,DST似乎反映了抑郁病理生理学的严重程度,这或许能为监测ECT治疗进展的临床医生提供系列反馈。

相似文献

1
Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy.仅接受电休克治疗的抑郁症患者的系列地塞米松抑制试验。
J Affect Disord. 1987 Nov-Dec;13(3):233-40. doi: 10.1016/0165-0327(87)90042-5.
2
Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.接受电休克治疗的单相抑郁症患者连续地塞米松抑制试验的变化
Biol Psychiatry. 1981 Jun;16(6):551-60.
3
Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.对接受电休克治疗的初始抑制者和非抑制者进行系列地塞米松抑制试验。
Biol Psychiatry. 1987 Apr;22(4):463-72. doi: 10.1016/0006-3223(87)90168-5.
4
Are serial dexamethasone suppression tests useful in electroconvulsive therapy?
J Affect Disord. 1986 Jan-Feb;10(1):59-66. doi: 10.1016/0165-0327(86)90049-2.
5
Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.地塞米松抑制试验的正常化:原发性抑郁症临床改善的一个相关因素。
Br J Psychiatry. 1985 Jul;147:30-5. doi: 10.1192/bjp.147.1.30.
6
Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.地塞米松抑制试验在忧郁症抗抑郁治疗中的应用。恢复正常的过程及重测信度
Arch Gen Psychiatry. 1983 May;40(5):493-500. doi: 10.1001/archpsyc.1983.01790050019002.
7
Dexamethasone suppression test and selection of antidepressant medications.地塞米松抑制试验与抗抑郁药物的选择
J Affect Disord. 1981 Dec;3(4):389-96. doi: 10.1016/0165-0327(81)90007-0.
8
A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.在使用抗抑郁药物治疗之前及治疗期间,对地塞米松抑制试验中地塞米松和皮质醇血浆浓度进行纵向评估。
Acta Psychiatr Scand. 1990 Dec;82(6):427-32. doi: 10.1111/j.1600-0447.1990.tb03073.x.
9
Clinical and DST response to bilateral sinusoidal but not to unilateral brief-pulse ECT.临床及药物敏感性试验对双侧正弦波电休克治疗有反应,但对单侧短脉冲电休克治疗无反应。
J Clin Psychiatry. 1986 Nov;47(11):557-9.
10
The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.地塞米松抑制试验:其与诊断、抑郁严重程度及治疗反应的关系。
Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(1-2):99-117. doi: 10.1016/0278-5846(89)90007-9.

引用本文的文献

1
Electroceutical and Bioelectric Therapy: Its Advantages and Limitations.电制药与生物电疗法:其优势与局限性
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):19-31. doi: 10.9758/cpn.2023.21.1.19.
2
Factors Affecting Electroconvulsive Therapy Ictal Outcomes: Duration and Postictal Suppression.影响电休克治疗发作期结果的因素:持续时间和发作后抑制。
AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:672-679. eCollection 2019.
3
Electroconvulsive therapy and its different indications.电休克治疗及其不同适应证。
Dialogues Clin Neurosci. 2008;10(1):105-17. doi: 10.31887/DCNS.2008.10.1/tcbaghai.